Vydané akcie společnosti Navidea Biopharmaceuticals Inc
Jaká je hodnota metriky Vydané akcie společnosti Navidea Biopharmaceuticals Inc?
Hodnota metriky Vydané akcie společnosti Navidea Biopharmaceuticals Inc je 100.084M
Jaká je definice metriky Vydané akcie?
Vydané akcie (Shares outstanding) je počet všech akcií společnosti nebo finančních aktiv, které byly autorizované, vydané a koupené investory a jsou jimi vlastněné.
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
Vydané akcie společností v sektoru Health Care sektor na NYSEMKT ve srovnání se společností Navidea Biopharmaceuticals Inc
Čemu se věnuje společnost Navidea Biopharmaceuticals Inc?
navidea biopharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. it operates through two segments, diagnostic substances and therapeutic development programs. the company develops manocept platform to target the cd206 mannose receptor expressed on activated macrophages. its cd206-targeted drug platform is applicable to a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (pet), imaging and topical gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. further, the company offers nav4694, a fluorine-18 labeled pet imaging agent for use as an aid in the imaging and evaluation of patients with signs or symptoms of alzheimer's disease and mild cognitive impairment. in addition, it is de
Firmy s metrikou vydané akcie podobnou společnosti Navidea Biopharmaceuticals Inc
- Hodnota metriky Vydané akcie společnosti Milton Capital Plc je 100.000M
- Hodnota metriky Vydané akcie společnosti Munjal Auto Industries je 100.000M
- Hodnota metriky Vydané akcie společnosti Beijing Jingcheng Machinery Electric je 100.000M
- Hodnota metriky Vydané akcie společnosti Satia Industries je 100.000M
- Hodnota metriky Vydané akcie společnosti Satia Industries je 100.000M
- Hodnota metriky Vydané akcie společnosti Marifil Mines je 100.075M
- Hodnota metriky Vydané akcie společnosti Navidea Biopharmaceuticals Inc je 100.084M
- Hodnota metriky Vydané akcie společnosti Mind Gym plc je 100.106M
- Hodnota metriky Vydané akcie společnosti Plus500 je 100.117M
- Hodnota metriky Vydané akcie společnosti Sprouts Farmers Market Inc je 100.130M
- Hodnota metriky Vydané akcie společnosti Simply Good Foods Co je 100.136M
- Hodnota metriky Vydané akcie společnosti Northern Oil and Gas je 100.172M
- Hodnota metriky Vydané akcie společnosti Premier Inc je 100.188M